Characteristics of the patients studied for the “external” validation of the Follicular Lymphoma International Prognostic Index (FLIPI)
Characteristic . | Number of patients (%) . |
|---|---|
| Age | |
| Younger than 60 y | 626 (68) |
| 60 y or older | 293 (32) |
| Ann Arbor stage | |
| I-II | 191 (21) |
| III-IV | 729 (79) |
| LDH | |
| Less than or equal to ULN | 709 (77) |
| Greater than ULN | 210 (23) |
| Hemoglobin level | |
| Less than 120 g/L | 178 (19) |
| Greater than or equal to 120 g/L | 741 (81) |
| Number of nodal sites | |
| Less than or equal to 4 | 568 (62) |
| Greater than 5 | 351 (38) |
| FLIPI | |
| Low* | 345 (38) |
| Intermediate† | 320 (35) |
| High‡ | 254 (28) |
Characteristic . | Number of patients (%) . |
|---|---|
| Age | |
| Younger than 60 y | 626 (68) |
| 60 y or older | 293 (32) |
| Ann Arbor stage | |
| I-II | 191 (21) |
| III-IV | 729 (79) |
| LDH | |
| Less than or equal to ULN | 709 (77) |
| Greater than ULN | 210 (23) |
| Hemoglobin level | |
| Less than 120 g/L | 178 (19) |
| Greater than or equal to 120 g/L | 741 (81) |
| Number of nodal sites | |
| Less than or equal to 4 | 568 (62) |
| Greater than 5 | 351 (38) |
| FLIPI | |
| Low* | 345 (38) |
| Intermediate† | 320 (35) |
| High‡ | 254 (28) |